130 related articles for article (PubMed ID: 27994831)
21. Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.
Şahin H; Karatas F; Coban G; Özen Ö; Erdem Ö; Onan MA; Ayhan A
J Gynecol Oncol; 2019 Jul; 30(4):e54. PubMed ID: 31074239
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory myofibroblastic tumor of the uterus - case report.
Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O
Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556
[TBL] [Abstract][Full Text] [Related]
23. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
[TBL] [Abstract][Full Text] [Related]
24. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
[TBL] [Abstract][Full Text] [Related]
25. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
Ip PP; Cheung AN; Clement PB
Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
[TBL] [Abstract][Full Text] [Related]
26. Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The Art.
Rizzo A; Ricci AD; Saponara M; DE Leo A; Perrone AM; DE Iaco P; Pantaleo MA; Nannini M
Anticancer Res; 2020 Mar; 40(3):1229-1238. PubMed ID: 32132019
[TBL] [Abstract][Full Text] [Related]
27. Uterine smooth-muscle tumors of uncertain malignant potential.
Peters WA; Howard DR; Andersen WA; Figge DC
Obstet Gynecol; 1994 Jun; 83(6):1015-20. PubMed ID: 8190416
[TBL] [Abstract][Full Text] [Related]
28. STUMP, a surprise finding in a large fibroid uterus in a 20-year-old woman.
Hughes L; Roex A; Parange A
Int J Womens Health; 2018; 10():211-214. PubMed ID: 29765254
[TBL] [Abstract][Full Text] [Related]
29. Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature.
Vilos GA; Marks J; Ettler HC; Vilos AG; Prefontaine M; Abu-Rafea B
J Minim Invasive Gynecol; 2012; 19(3):288-95. PubMed ID: 22546421
[TBL] [Abstract][Full Text] [Related]
30. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
[TBL] [Abstract][Full Text] [Related]
31. Primary leiomyosarcoma of bone: clinicopathologic, immunohistochemical, and molecular biologic aspects.
Wirbel RJ; Verelst S; Hanselmann R; Remberger K; Kubale R; Mutschler WE
Ann Surg Oncol; 1998; 5(7):635-41. PubMed ID: 9831113
[TBL] [Abstract][Full Text] [Related]
32. ["STUMP" (smooth muscle tumour of uncertain malignant potential), a tumour of the uterus in pregnancy--a diagnostic and therapeutic challenge].
Clauss S; Höller S; Hegi L; Blum R; Hösli I
Z Geburtshilfe Neonatol; 2010 Apr; 214(2):74-7. PubMed ID: 20411475
[TBL] [Abstract][Full Text] [Related]
33. Intraosseous leiomyoma of the calcaneum: An unusual bone tumor of foot and review of literature.
Salunke AA; Vala PC; Singh H; Parwani R; Gandhi S; Shah D
J Clin Orthop Trauma; 2016; 7(Suppl 1):61-64. PubMed ID: 28018075
[TBL] [Abstract][Full Text] [Related]
34. High 18F-FDG uptake for uterine smooth muscle tumor of uncertain malignant potential.
Zhang R; Tian X; Qin L; Lu D; Shen J
Clin Nucl Med; 2015 Apr; 40(4):349-51. PubMed ID: 25674868
[TBL] [Abstract][Full Text] [Related]
35. Patterns of Chromosomal Abnormalities that Can Improve Diagnosis of Uterine Smooth Muscle Tumors.
Holzmann C; Markowski DN; VON Leffern I; Löning T; Bullerdiek J
Anticancer Res; 2015 Dec; 35(12):6445-56. PubMed ID: 26637855
[TBL] [Abstract][Full Text] [Related]
36. Uterine smooth muscle tumors of unknown malignant potential: A challenging question.
Gadducci A; Zannoni GF
Gynecol Oncol; 2019 Sep; 154(3):631-637. PubMed ID: 31326137
[TBL] [Abstract][Full Text] [Related]
37. Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases.
Huo L; Wang D; Wang W; Cao D; Yang J; Wu M; Yang J; Xiang Y
Front Oncol; 2020; 10():647. PubMed ID: 32477938
[No Abstract] [Full Text] [Related]
38. Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors.
Esposito NN; Hunt JL; Bakker A; Jones MW
Am J Surg Pathol; 2006 Jan; 30(1):97-103. PubMed ID: 16330948
[TBL] [Abstract][Full Text] [Related]
39. Intraosseous Leiomyoma of the Tibia. A Case Report.
Abdelaal AH; Yamamoto N; Hayashi K; Takeuchii A; Tsuchiyai H
J Orthop Case Rep; 2016; 6(2):81-85. PubMed ID: 27703944
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma.
Dastranj Tabrizi A; Ghojazadeh M; Thagizadeh Anvar H; Vahedi A; Naji S; Mostafidi E; Berenjian S
Adv Pharm Bull; 2015 Dec; 5(Suppl 1):683-7. PubMed ID: 26793616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
